Thrombolytic therapy for acute arterial occlusion11Dr. Ouriel is a consultant for Abbott Laboratories. He receives research support from Centocor and Genentech.-Reference-Cited by-同舟云学术

Thrombolytic therapy for acute arterial occlusion11Dr. Ouriel is a consultant for Abbott Laboratories. He receives research support from Centocor and Genentech.

Published:2002-01 Issue:1 Volume:194 Page:S32-S39
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Ouriel Kenneth

Publisher

Elsevier BV

Subject

Surgery

Reference15 articles.

1. Sur les obstructions des thrombus arterielles anciennes;Dos Santos;Mem Acad Chir,1949

2. Management of acute lower extremity arterial ischemia due to embolism and thrombosis;Blaisdell;Surgery,1978

3. Surgical management of severe acute lower extremity ischemia;Yeager;J Vasc Surg,1992

4. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia;Ouriel;J Vasc Surg,1994

5. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients;Tillett;J Clin Invest,1955

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusions;Journal of Vascular Surgery;2017-05

2. Urokinase-CdSe/ZnS Core/Shell Conjugates for Targeted Fibrinolytic Treatment: An In Vitro Evaluation;Journal of Biomaterials and Tissue Engineering;2014-10-01

3. Fibrinogen Level as a Surrogate for the Outcome of Thrombolytic Therapy Using Tissue Plasminogen Activator for Acute Lower Extremity Intravascular Thrombosis;Vascular and Endovascular Surgery;2013-07-29

4. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: Anin vitrothrombolysis study;Journal of Biomedical Materials Research Part A;2009-12-01

5. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles;Biomaterials;2008-01